JUNS · Jupiter Neurosciences, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“In management's opinion, these conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of at least twelve months from the date of this report.”View the 10-Q filed May 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-22 | Cutler Andrew Jon |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-29 | Philipson Tomas Jan |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Represents a grant of 536,428 stock options (each representing the right to purchase one share of Common Stock) under the Issuer's 2025 Equity Incentive Plan. Of this amount, 90,000 options were granted in connection with the Reporting Person's appointment to the Board of Directors and 446,428 options were granted in lieu of cash compensation otherwise payable as an annual board retainer and committee fees. The options vest in 12 equal quarterly installments beginning September 2, 2026, subject to the Reporting Person's continued service as a director through each vesting date. |
Stock Option (right to buy)
|
536,428 |
| 2026-06-26 | Philipson Tomas Jan |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-02 | Hemmerly Nicholas H. |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date. |
Stock Option
|
100,000 |
| 2026-06-02 | Rosen Alexander Gustaf Erik |
Chief Administrative Officer |
Award↑
Filing footnotes — Stock Option (Direct)
341,843 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date. |
Stock Option
|
341,843 |
| 2026-06-02 | Kampf Julie B. |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date. |
Stock Option
|
100,000 |
| 2026-06-02 | Brady Allison W |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date. |
Stock Option
|
100,000 |
| 2026-06-02 | Elmasri Saleem |
CFO and Secretary |
Award↑
Filing footnotes — Stock Option (Direct)
325,565 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. 200,000 options were granted under the Issuer's 2025 Equity Incentive Plan as long-term incentive compensation. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date. |
Stock Option
|
525,565 |
| 2026-06-02 | Hayward Marshall A. |
Director, Chief Scientific Officer |
Award↑
Filing footnotes — Stock Option (Direct)
259,231 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date. |
Stock Option
|
259,231 |
| 2026-06-02 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Award↑
Filing footnotes — Stock Option (Direct)
747,783 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date. |
Stock Option
|
747,783 |
| 2026-06-02 | Weis Holger |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date. |
Stock Option
|
100,000 |
| 2026-06-02 | Silva Alison D. |
Pres + Chief Business Officer |
Award↑
Filing footnotes — Stock Option (Direct)
427,304 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. 600,000 options were granted under the Issuer's 2025 Equity Incentive Plan as long-term incentive compensation. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date. |
Stock Option
|
1,027,304 |
| 2026-03-02 | Hayward Marshall A. |
Director, Chief Scientific Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The shares underlying this option vested 100% on January 1, 2016 under the Company's 2016 Equity Incentive Plan. |
Common Stock
|
225,000 |
| 2026-03-02 | Hayward Marshall A. |
Director, Chief Scientific Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The shares underlying this option vested 100% on January 1, 2016 under the Company's 2016 Equity Incentive Plan. |
Stock Option (right to buy)
|
225,000 |
| 2025-07-02 | Silva Alison D. |
Pres + Chief Business Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options were granted under the Issuer's 2023 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2024. The options vest in three equal installments over a three (3) year, beginning on July 2, 2025. |
Stock Option (right to buy)
|
255,320 |
| 2025-07-02 | Elmasri Saleem |
CFO and Secretary |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options were granted under the Issuer's 2023 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2024. The options vest in three equal installments over a three (3) year, beginning on July 2, 2025. |
Stock Option (right to buy)
|
102,128 |
| 2025-07-01 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-07-01 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-07-01 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-07-01 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
500 |
| 2025-07-01 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
3,100 |
| 2025-06-30 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
1,450 |
| 2025-06-30 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-06-30 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
700 |
| 2025-06-30 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
100 |
| 2025-06-30 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-06-30 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
1,000 |
| 2025-06-30 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
100 |
| 2025-06-30 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
2,000 |
| 2025-06-30 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
1,000 |
| 2025-06-30 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
1,500 |
| 2025-06-30 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-06-27 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-06-27 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Buy↑
|
Common Stock
|
166 |
| 2025-06-27 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-06-27 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
100 |
| 2025-06-27 | Silva Alison D. |
Pres + Chief Business Officer |
Buy↑
|
Common Stock
|
250 |
| 2025-06-02 | Kampf Julie B. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
These restricted stock units convert into common stock on a one-for-one basis. Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering. |
Restricted Stock Units
|
82,875 |
| 2025-06-02 | Hemmerly Nicholas H. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
These restricted stock units convert into common stock on a one-for-one basis. |
Common Stock
|
95,550 |
| 2025-06-02 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents Restricted Stock Units that vested upon expiration of the lock-up period. |
Common Stock
|
497,396 |
| 2025-06-02 | Weis Holger |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
These restricted stock units convert into common stock on a one-for-one basis. |
Common Stock
|
85,800 |
| 2025-06-02 | Rosen Alexander Gustaf Erik |
Chief Administrative Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
These securities convert into common stock on a one-for-one basis. |
Common Stock
|
96,608 |
| 2025-06-02 | Hayward Marshall A. |
Director, Chief Scientific Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
These securities convert into common stock on a one-for-one basis. |
Common Stock
|
389,793 |
| 2025-06-02 | Silva Alison D. |
Pres + Chief Business Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units which vested on the expiration of the lock-up period. |
Common Stock
|
110,227 |
| 2025-06-02 | Hemmerly Nicholas H. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
These restricted stock units convert into common stock on a one-for-one basis. Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering. |
Restricted Stock Units
|
95,550 |
| 2025-06-02 | Elmasri Saleem |
CFO and Secretary |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering. |
Common Stock
|
66,293 |
| 2025-06-02 | ROSEN CHRISTER |
Director, CEO and Chairman, 10% Owner |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents Restricted Stock Awards that vested upon expiration of the lock-up period. |
Common Stock
|
476,070 |
| 2025-06-02 | Rosen Alexander Gustaf Erik |
Chief Administrative Officer |
Convert↓
Filing footnotes — Restricted Stock Award (Direct)
These securities convert into common stock on a one-for-one basis. These awards vested on the expiration of the lock-up period for the Issuer's initial public offering. |
Restricted Stock Award
|
96,608 |
| 2025-06-02 | Weis Holger |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
These restricted stock units convert into common stock on a one-for-one basis. Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering. |
Restricted Stock Units
|
85,800 |
| 2025-06-02 | Hayward Marshall A. |
Director, Chief Scientific Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
These securities convert into common stock on a one-for-one basis. These awards vested on the expiration of the lock-up period for the Issuer's initial public offering. |
Restricted Stock Units
|
389,793 |